Member News

Event honors Gary Felsenfeld

Thoru Pederson Bruce Alberts
By Thoru Pederson and Bruce Alberts
Feb. 12, 2024

A celebration honoring Gary Felsenfeld, a pioneer in the study of nucleic acid structure and chromatin, brought together more than 25 of his former National Institutes of Health lab members recently to offer reminiscences. Inspired by our decades-long admiration of Felsenfeld, the authors organized this event in Washington, D.C.

Group photo of event celebrating Gary Felsenfeld.
Daniel Felsenfeld
Longtime NIH researcher Gary Felsenfeld, center, is surrounded by former lab members and admirers during a celebration in January at the Cosmos Club in Washington, D.C.

Felsenfeld’s career spanned three eras of biophysical chemistry and molecular biology.  He was the first, with David Davies and Alex Rich, to demonstrate the existence of three-stranded RNA and (independently with Stuart Orkin) identified GATA1, an early discovery of an erythroid gene regulatory factor.   In the 1970s, he made a major discovery on the structure of chromatin and later defined key regulatory elements of gene expression, including “insulator” elements and the transcription factor CTCF. 

A member of the American Society for Biochemistry and Molecular Biology for more than 60 years who served on the Journal of Biological Chemistry editorial board in the 1960s, Felsenfeld has received many honors in his career but this was a very personal one, as we intended and as he described it afterwards. 

During the evening, Felsenfeld shared memories of some of his mentors, including protein scientist John Edsall at Harvard, where Felsenfeld was an undergraduate, and two-time Nobel Prize winner, biochemist and peace activist Linus Pauling at the California Institute of Technology, where Felsenfeld earned his Ph.D. — an enriching historical connection for most of the guests who knew these scientists by name only. 

Felsenfeld, soon to be 95, spent almost his entire career at the National Institutes of Health, where he served as the Molecular Biology Section chief in the National Institute of Diabetes and Digestive and Kidney Diseases and is now an NIH distinguished investigator and scientist emeritus.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Thoru Pederson
Thoru Pederson

Thoru Pederson is a professor of biochemistry and molecular biotechnology at the University of Massachusetts Chan Medical School.

Bruce Alberts
Bruce Alberts

Bruce Alberts is a professor of biochemistry and biophysics, University of California San Francisco.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

In memoriam: Alan G. Goodridge
In Memoriam

In memoriam: Alan G. Goodridge

Dec. 9, 2025

He made pioneering discoveries on lipid metabolism and was an ASBMB member since 1971.

Alrubaye wins research and teaching awards
Member News

Alrubaye wins research and teaching awards

Dec. 8, 2025

He was honored at the NACTA 2025 conference for the Educator Award and at the U of A State and National Awards reception for the Faculty Gold Medal.

Designing life’s building blocks with AI
Profile

Designing life’s building blocks with AI

Dec. 2, 2025

Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.

Jordahl named Gilliam Fellow
Member News

Jordahl named Gilliam Fellow

Dec. 1, 2025

He will receive three years of funding to support his thesis research.

Bibel named assistant professor
Member News

Bibel named assistant professor

Nov. 24, 2025

She began her position at Loyola Marymount University in August 2025.

Unraveling the language of histones
Profile

Unraveling the language of histones

Nov. 20, 2025

Philip Cole presented his research on how posttranslational modifications to histones are involved in gene expression and how these modifications could be therapeutically targeted to treat diseases like cancer.